FASLG and ovarian cancer: In addition to reprogramming the immune cell gene profile, ovarian cancer cells release Fas ligand (FasL)-carrying exosomes which downregulate the expression of the surface T cell receptors/CD3-zeta (ζ) and promote T cell apoptosis [87].